HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Radiosurgery for glomus jugulare tumors: experience treating 16 patients in Iran.

AbstractOBJECT:
Glomus jugulare tumors (GJT) have traditionally been treated by surgery or fractionated external-beam radiotherapy. The aim of this retrospective study was to determine the tumor control rate, clinical outcome, and short-term complications of stereotactic radiosurgery in subsets of patients who are poor candidates for these procedures, based on age, medical problems, tumor size, or prior treatment failure.
METHODS:
The Leksell Gamma Knife was used to treat 16 patients harboring symptomatic, residual, recurrent, or unresectable GJTs. The age of the patients ranged from 12 to 77 years (median 46.5 years). Gamma Knife surgery (GKS) was performed as primary treatment in five patients (31.3%). Microsurgery preceded radiosurgery in 10 patients (62.5%) and fractionated radiotherapy in three patients (18.8%). The median tumor volume was 9.8 cm3 (range 1.7-20.6 cm3). The median marginal dose applied to a mean isodose volume of 50% (range 37-70%) was 18 Gy (range 14-20 Gy). Neurological follow-up examinations revealed improved clinical status in 10 patients (62.5%), a stable neurological status in six (37.5%), and no complications. After radiosurgery, follow-up imaging was conducted in 14 patients; the median interval from GKS to the last follow up was 18.5 months (range 4-28 months). Tumor size had decreased in six patients (42.9%), and the volume remained unchanged in the remaining eight (57.1%). None of the tumors increased in volume during the observation period.
CONCLUSIONS:
According to the authors' experience, GKS represents a useful therapeutic option to control symptoms and may be safely conducted in patients with primary or recurrent GJTs with no death and no acute morbidity. Because of the tumor's naturally slow growth rate, however, long-term follow-up data are needed to establish a cure rate after radiosurgery.
AuthorsMohammad Ali Bitaraf, Mazdak Alikhani, Pouya Tahsili-Fahadan, Rouzbeh Motiei-Langroudi, Alireza Zahiri, Mahmoud Allahverdi, Soraya Salmanian
JournalJournal of neurosurgery (J Neurosurg) Vol. 105 Suppl Pg. 168-74 (Dec 2006) ISSN: 0022-3085 [Print] United States
PMID18503352 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Cohort Studies
  • Disease-Free Survival
  • Female
  • Glomus Jugulare Tumor (complications, pathology, surgery)
  • Humans
  • Iran
  • Male
  • Middle Aged
  • Radiosurgery
  • Retrospective Studies
  • Treatment Outcome
  • Tumor Burden
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: